CD14CD16 monocyte subset levels in heart failure patients

Disease Markers

Volumn 28, Issue 2, 2010, Pages 115-124

  Barisione, Chiara ^a   Garibaldi, Silvano ^a   Ghigliotti, Giorgio ^a   Fabbi, Patrizia ^a   Altieri, Paola ^a   Casale, Maria Carla ^a   Spallarossa, Paolo ^a   Bertero, Giovanni ^a   Balbi, Manrico ^a   Corsiglia, Luca ^b   Brunelli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Casa di Cura Istituto Cardiovascolare Camogli (ISC)   (Italy)

Author keywords

Angiotensin; antigens; CD14; chronic; congestive heart failure; IgG; kidney failure; monocytes; peptidyl dipeptidase A; receptors

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CD14 ANTIGEN; CD16 ANTIGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CELL EXPANSION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; ENZYMOLOGY; HEART FAILURE; IMMUNOLOGY; KIDNEY; LEUKOCYTE COUNT; METABOLISM; NEUTROPHIL; PATHOPHYSIOLOGY;

AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; HEART FAILURE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; LEUKOCYTE COUNT; MALE; MONOCYTES; NEUTROPHILS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, IGG;

EID: 77954062061     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0691     Document Type: Article

References (28)

1. H.J. Dargie and J.J. McMurray, Diagnosis and management of heart Failure, BMJ 308 (1994), 321-328.
2. R.T. Tsuyuki, M.C. Shibata, C. Nilsson and M. Hervas-Malo, Contemporary burden of illness of congestive heart failure in Canada, Can J Cardiol 19 (2003), 436-438.
3. S. Heymans, E. Hirsch, S.D. Anker, P. Aukrust, J.L. Balligand, J.W. Cohen-Tervaert, H. Drexler, G. Filippatos, S.B. Felix, L. Gullestad, D. Hilfiker-Kleiner, S. Janssens, R. Latini, G. Neubauer, W.J. Paulus, B. Pieske, P. Ponikowski, B. Schroen, H.P. Schultheiss, C. Tschöpe, M. Van Bilsen, F. Zannad, J. McMurray and A.M. Shah, Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail 11 (2009), 119-129.
4. W.A. Nockher, J. Wiemer and J.E. Scherberich, Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets, Clin Exp Immunol 123 (2001), 49-55.
5. J. Skrzeczýnska-Moncznik, M. Bzowska, S. Loseke, E. Grage-Griebenow, M. Zembala and J. Pryjma, Peripheral blood CD14high CD16+ monocytes are main producers of IL-10, Scand J Immunol 67 (2008), 152-159.
6. V.J. Dzau, K. Bernstein, D. Celermajer, J. Cohen and M. Weber, Pathophysiologic and therapeutic importance of tissue ACE: a consensus report, Cardiovasc Drugs Ther 16 (2002), 149-160.
7. S.M. Danilov, E. Sadovnikova, N. Scharenborg, I.V. Balyasnikova, D.A. Svinareva, E.L. Semikina, E.N. Parovichnikova, V.G. Savchenko and G.J. Adema, Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells, Exp Hematol 31 (2003), 1301-1309.
8. C. Ulrich, G.H. Heine, P. Garcia, B. Reichart, T. Georg, M. Krause, H. Köhler and M. Girndt, Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease, Nephrol Dial Transplant 21 (2006), 1596-1602.
9. N. Kawanaka, M. Yamamura, T. Aita, Y Morita, A. Okamoto, M. Kawashima, M. Iwahashi, A. Ueno, Y. Ohmoto and H. Makino, CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis, Arthritis Rheum 46 (2002), 2578-2586.
10. H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, M. Yamada, M. Kikuyama, Y. Maruyama, Y. Iwaoka, K. Hirayama, S. Nagata and K. Takai, Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with in-flammatory bowel disease, Am J Gastroenterol 103 (2008), 1210-1216.
11. M. Moniuszko, A. Bodzenta-Lukaszyk, K. Kowal, D. Lenczewska and M. Dabrowska, Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients, Clin Immunol 130 (2009), 338-346.
12. S.D. Anker, K.R. Egerer, H.D. Volk, W.J. Kox, P.A. Poole-Wilson and A.J. Coats, Elevated soluble CD14 receptors and altered cytokines in chronic heart failure, Am J Cardiol 79 (1997), 1426-1430.
13. P.A. McKee, W.P. Castelli, P.M. McNamara andW.B. Kannel, The natural history of congestive heart failure: the Framingham study, N Engl J Med 285 (1971), 1441-1446.
14. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers and D. Roth, Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Ann Intern Med 130 (1999), 461-470.
15. P. de Groote, R Isnard, P. Clerson, G. Jondeau, M. Galinier, P. Assyag, N. Demil, A. Ducardonnet, J.F. Thebaut and M. Komajda, Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme, Eur J Heart Fail 11 (2009), 85-91.
16. J. Mestas and K. Ley, Monocyte-endothelial cell interactions in the development of atherosclerosis, Trends Cardiovasc Med 18 (2008), 228-232.
17. H.W. Ziegler-Heitbrock, Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation, Immunol Today 17 (1996), 424-428.
18. S. Gordon and P.R. Taylor, Monocyte and macrophage heterogeneity, Nat Rev Immunol 5 (2005), 953-964.
19. K.U. Belge, F. Dayyani, A. Horelt, M. Siedlar, M. Frankenberger, B. Frankenberger, T. Espevik and L. Ziegler-Heitbrock, The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF, J Immunol 168 (2002), 3536-3542.
20. C. Weber, K.U. Belge, P. von Hundelshausen, G. Draude, B. Steppich, M. Mack, M. Frankenberger, K.S. Weber and H.W. Ziegler-Heitbrock, Differential chemokine receptor expression and function in human monocyte subpopulations, J Leukoc Biol 67 (2000), 699-704.
21. J.E. Scherberich and W.A. Nockher, CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy, Clin Chem Lab Med 37 (1999), 209-213.
22. A. Schlitt, G.H. Heine, S. Blankenberg, C. Espinola-Klein, J.F. Dopheide, C. Bickel, K.J. Lackner, M. Iz, J. Meyer, H. Darius and H.J. Rupprecht, CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels, Thromb Haemost 92 (2004), 419-424.
23. G. Földes, S. von Haehling, D.O. Okonko, E.A. Jankowska, P.A. Poole-Wilson and S.D. Anker, Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure, Int J Cardiol 124 (2008), 80-85.
24. E. Braunwald, The Denolin lecture. Congestive heart failure: a half century perspective, Eur Heart J 22 (2001), 825-836.
25. W.H. Tang, M.L. Brennan, K. Philip, W. Tong, S. Mann, F. Van Lente and S.L. Hazen, Plasma myeloperoxidase levels in patients with chronic heart failure, Am J Cardiol 98 (2006), 796-799.
26. P. Ancuta, R. Rao, A. Moses, A. Mehle, S.K. Shaw, F.W. Luscinskas and D. Gabuzda, Fractalkine preferentially mediates arrest and migration of CD16+ monocytes, J Exp Med 197 (2003), 1701-1707.
27. N. Bardin, V. Moal, F. Anfosso, L. Daniel, P. Brunet, J. Sampol and G.F. Dignat, Soluble CD146, a novel endothelialmarker, is increased in physiopathological settings linked to endothelial junctional alteration, Thromb Haemost 90 (2003), 915-920.
28. J. Sundström, Myocardial biomarkers for prediction of cardiovascular disease, Dis Markers 26 (2009), 235-246.